NLRC5 and glioma: Consequently, the molecular mechanism revealed that knockdown of SCAMP1 increased miR‐499a‐5p expression, which hindered the expression of LMX1A and NLRC5, further led to carcinostatic effects on glioma cells by repressing the activity of Wnt/β‐catenin signalling pathway.